English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 11 October 2017, 09:15 HKT/SGT
Share:
    

Source: New Silkroutes Group Limited
New Silkroutes Group to Add More Clinics to Dental Portfolio to Further Expand Healthcare Business
Acquisition of The Dental Hub's 3 clinics will expand NSG's dental portfolio to 9 clinics and 2 dental supplies companies

SINGAPORE, Oct 11, 2017 - (ACN Newswire) - Healthsciences International Pte Ltd ("HSI"), through its fully owned subsidiary HSI Nominees A Pte Ltd, will pay approximately S$3.2 million to acquire a 70% stake in three dental clinics in Singapore as part of efforts to accelerate its growth. HSI is a subsidiary of New Silkroutes Group Limited ("NSG" or the "Group") and holds the Group's healthcare investments.

The move comes just four months after HSI completed the acquisition of majority control of six dental clinics and two dental supplies companies in Singapore in a major push to expand its healthcare capabilities. NSG acquired HSI in December 2016 in a deal that valued the healthcare company at S$4.25 million.

The three clinics to be acquired currently operate under The Dental Hub brand and are located at Bedok North Street 4, PSA Building at Alexandra Road, and Yew Tee Point at Choa Chu Kang. Collectively, they generated about S$2.7 million in revenue and S$0.5 million in earnings in their last financial year.

Following this acquisition, which is expected to be completed by 30 October 2017, HSI will have nine dental clinics and two dental supplies companies, making it one of the fastest-growing dental chains in Singapore.

Besides the dental business, HSI also has two clinics in Singapore providing complementary integrative therapies based on Western standards of medical care. HSI, in which NSG has a 69.35% stake, also operates clinic and pharmacy management systems in Singapore and China.

NSG will issue approximately 7.2 million new shares at 44 Singapore cents each as consideration for The Dental Hub clinics, which are currently equally owned by two dental practitioners, Dr Ainsley Toh and Dr Foong Siew Hong.

Dr Goh Jin Hian, NSG's Group Chief Executive Officer, said: "We are beginning to establish our healthcare services platform, which will eventually include medical specialist services and hospital management. Although we are starting with small steps in Singapore, HSI aspires to be a regional healthcare player in time to come."

New Silkroutes Capital Pte Ltd ("NSC"), a wholly owned subsidiary of NSG, will be responsible for raising funds to support the growth of HSI. NSC, the Group's financial services arm, is expanding its capabilities to focus on wealth management, investment banking, as well as private equity and venture capital financing in the energy, healthcare and real estate sectors.

About New Silkroutes Group Limited

New Silkroutes Group (Reuters: NEWS.SI; Bloomberg: NSG SP) is a Singapore-incorporated investment holding company listed on the Mainboard of Singapore Exchange Securities Trading Ltd (SGX). The group, through its subsidiaries and associate companies, focuses on these key sector verticals: Financials, Energy/Resources, Healthcare and Real Estate.

For enquiries, please contact:
New Silkroutes Group Limited
Email: ipr@newsilkroutes.org

Topic: Press release summary
Source: New Silkroutes Group Limited

Sectors: Daily Finance, Healthcare & Pharm
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

New Silkroutes Group Limited Related News
Mar 25, 2019 19:00 HKT/SGT
New Silkroutes Group sells its energy unit for US$10 million
Oct 19, 2017 11:00 HKT/SGT
新丝路集团投资部门将收购欧洲基金管理公司Culross Global 66% 的股份
Oct 19, 2017 11:00 HKT/SGT
新絲路集團投資部門將收購歐洲基金管理公司Culross Global 66% 的股份
Oct 19, 2017 09:30 HKT/SGT
New Silkroutes Group to Acquire 66% Stake in European Fund Manager Culross Global
Oct 11, 2017 09:15 HKT/SGT
新丝路集团再收购多间牙科诊所 进一步拓展其医疗保健业务
More news >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575